Items 1 to 10 of about 53329
1. Atkinson KV, Bishop LA, Rhodes G, Salez N, McEwan NR, Hegarty MJ, Robey J, Harding N, Wetherell S, Lauder RM, Pickup RW, Wilkinson M, Gatherer D: Influenza C in Lancaster, UK, in the winter of 2014-2015. Sci Rep; 2017 Apr 13;7:46578

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Influenza C in Lancaster, UK, in the winter of 2014-2015.
  • We performed nasopharyngeal or nasal swabbing and/or serum sampling (n = 148) in Lancaster, UK, over the winter of 2014-2015.
  • Although we find no evidence that influenza C was a significant respiratory pathogen during the winter of 2014-2015 in Lancaster, we confirm previous observations of seropositivity in the majority of the population. (170 words).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Infect. 1992 Jan;24(1):91-9 [1312564.001]
  • [Cites] Virology. 1986 Aug;153(1):12-21 [2943076.001]
  • [Cites] Mol Biol Evol. 1987 Jul;4(4):406-25 [3447015.001]
  • [Cites] Infect Immun. 1980 Nov;30(2):500-5 [7439993.001]
  • [Cites] J Infect Dis. 2006 May 1;193(9):1229-35 [16586359.001]
  • [Cites] Emerg Infect Dis. 2006 Oct;12(10):1621-2 [17176596.001]
  • [Cites] J Gen Virol. 1996 Apr;77 ( Pt 4):673-9 [8627255.001]
  • [Cites] Pediatr Infect Dis J. 2015 Nov;34(11):1273-5 [26244834.001]
  • [Cites] J Virol. 2016 Aug 26;90(18):8251-65 [27384661.001]
  • [Cites] J Virol. 2003 Jan;77(2):871-81 [12502803.001]
  • [Cites] Kurume Med J. 1983;30(3):121-3 [6323821.001]
  • [Cites] Brief Bioinform. 2013 Mar;14(2):193-202 [22445902.001]
  • [Cites] Arch Intern Med. 1980 Oct;140(10):1295-8 [7425764.001]
  • [Cites] Mol Biol Evol. 1992 Sep;9(5):814-25 [1528108.001]
  • [Cites] J Med Virol. 2014 May;86(5):879-85 [24122799.001]
  • [Cites] Arch Virol. 1978;58(4):341-8 [104696.001]
  • [Cites] J Clin Virol. 2016 Jan;74:50-3 [26655269.001]
  • [Cites] J Mol Evol. 2008 Jun;66(6):655-63 [18504518.001]
  • [Cites] Bioinformatics. 2009 Aug 15;25(16):2078-9 [19505943.001]
  • [Cites] Influenza Other Respir Viruses. 2013 Nov;7(6):999-1003 [23594251.001]
  • [Cites] Bioinformatics. 2010 Mar 1;26(5):589-95 [20080505.001]
  • [Cites] Nucleic Acids Res. 2004 Mar 19;32(5):1792-7 [15034147.001]
  • [Cites] Pediatr Infect Dis J. 2009 Jun;28(6):554 [19483529.001]
  • [Cites] J Virol. 1979 Dec;32(3):1006-14 [513198.001]
  • [Cites] Vopr Virusol. 1985 Nov-Dec;30(6):661-4 [4095973.001]
  • [Cites] J Gen Virol. 1994 Dec;75 ( Pt 12):3619-22 [7996155.001]
  • [Cites] Roum Arch Microbiol Immunol. 1992 Oct-Dec;51(4):263-9 [1304830.001]
  • [Cites] Br Med J. 1968 Oct 19;4(5624):153-4 [5681050.001]
  • [Cites] Rev Saude Publica. 2000 Apr;34(2):204-5 [10881159.001]
  • [Cites] PLoS One. 2010 Jun 17;5(6):e11184 [20567599.001]
  • [Cites] PLoS Curr. 2010 Nov 30;2:RRN1199 [21127722.002]
  • [Cites] Can Med Assoc J. 1966 Jan 22;94(4):159-63 [4379067.001]
  • [Cites] Virology. 1988 Mar;163(1):112-22 [3267218.001]
  • [Cites] Brief Bioinform. 2008 Jul;9(4):299-306 [18417537.001]
  • [Cites] J Virol. 2015 Oct;89(19):10130-2 [26202242.001]
  • [Cites] Genome Biol. 2009;10(3):R25 [19261174.001]
  • [Cites] J Pediatr. 1991 Feb;118(2):235-8 [1993950.001]
  • [Cites] Acta Virol. 1983 Nov;27(6):502-10 [6140836.001]
  • [Cites] J Infect. 2014 Aug;69(2):182-9 [24704348.001]
  • [Cites] J Clin Microbiol. 2007 Mar;45(3):783-8 [17215347.001]
  • [Cites] Virus Evol. 2016 Apr 09;2(1):vew007 [27774300.001]
  • [Cites] J Gen Virol. 1996 Jul;77 ( Pt 7):1489-92 [8757991.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9101-6 [22547828.001]
  • [Cites] BMC Evol Biol. 2007 Nov 08;7:214 [17996036.001]
  • [Cites] Methods Mol Biol. 2013;971:277-93 [23296970.001]
  • [Cites] J Med Virol. 2008 Aug;80(8):1441-6 [18551600.001]
  • [Cites] Bull World Health Organ. 1953;8(5-6):613-31 [13094497.001]
  • [Cites] Eur J Epidemiol. 1994 Feb;10(1):91-4 [7957798.001]
  • [Cites] Microbiol Immunol. 1987;31(11):1137-43 [3502168.001]
  • [ErratumIn] Sci Rep. 2017 May 26;7:46815 [28548112.001]
  • (PMID = 28406194.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Coughlin SS: Community-Based Participatory Research Studies on HIV/AIDS Prevention, 2005-2014. Jacobs J Community Med; 2016 Apr;2(1)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Community-Based Participatory Research Studies on HIV/AIDS Prevention, 2005-2014.
  • Published HIV prevention studies that employed CBPR methods were identified for the period January 1, 2005 to April 30, 2014 using PubMed databases and MeSH term and keyword searches.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS Patient Care STDS. 2012 Feb;26(2):116-24 [22149766.001]
  • [Cites] J Pediatr Psychol. 2006 Oct;31(9):905-16 [16452646.001]
  • [Cites] J Empir Res Hum Res Ethics. 2013 Apr;8(2):119-28 [23651936.001]
  • [Cites] Prog Community Health Partnersh. 2009 Winter;3(4):275-6 [20097988.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):173-83 [20528127.001]
  • [Cites] AIDS Care. 2007 Jul;19(6):799-810 [17573601.001]
  • [Cites] Cult Health Sex. 2010 Oct;12(7):797-812 [20582764.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):184-202 [20528128.001]
  • [Cites] Asia Pac J Public Health. 2010 Jul;22(3 Suppl):151S-158S [20566548.001]
  • [Cites] J Prev Interv Community. 2010;38(2):104-17 [20391058.001]
  • [Cites] Health Care Women Int. 2011 Apr;32(4):300-13 [21409663.001]
  • [Cites] AIDS Behav. 2013 May;17 Suppl 1:S33-42 [22903420.001]
  • [Cites] Health Promot Pract. 2011 Nov;12(6):823-31 [21511996.001]
  • [Cites] AIDS Behav. 2011 Nov;15(8):1764-75 [21301948.001]
  • [Cites] Promot Educ. 2007;14(3):150-4 [18154224.001]
  • [Cites] J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18644 [24242259.001]
  • [Cites] Cult Health Sex. 2011 Oct;13(9):1073-89 [21815839.001]
  • [Cites] Int Public Health J. 2012;4(3):301-308 [24489998.001]
  • [Cites] Contemp Clin Trials. 2010 Mar;31(2):151-6 [20035899.001]
  • [Cites] AIDS Educ Prev. 2010 Aug;22(4):371-85 [20707696.001]
  • [Cites] Health Promot Pract. 2011 Mar;12(2):293-302 [20685913.001]
  • [Cites] AIDS Educ Prev. 2007 Dec;19(6):531-44 [18190277.001]
  • [Cites] Am J Public Health. 2011 Apr;101(4):623-31 [20558812.001]
  • [Cites] Soc Sci Med. 2012 Aug;75(4):699-708 [22647562.001]
  • [Cites] AIDS Patient Care STDS. 2007 Nov;21(11):861-70 [18240895.001]
  • [Cites] Prog Community Health Partnersh. 2011 Winter;5(4):425-31 [22616210.001]
  • [Cites] Prev Sci. 2011 Mar;12(1):34-47 [21107693.001]
  • [Cites] AIDS Educ Prev. 2009 Oct;21(5 Suppl):103-8 [19824838.001]
  • [Cites] Ethn Dis. 2010 Winter;20(1 Suppl 2):S2-1-8 [20629240.001]
  • [Cites] Health Promot Pract. 2013 Jul;14(4):607-16 [23075504.001]
  • [Cites] Prog Community Health Partnersh. 2012 Winter;6(4):417-27 [23221286.001]
  • [Cites] Am J Health Behav. 2012 Jul;36(4):555-68 [22488405.001]
  • [Cites] AIDS Educ Prev. 2010 Feb;22(1):37-48 [20166786.001]
  • [Cites] AIDS Care. 2006 May;18(4):398-403 [16809119.001]
  • [Cites] BMC Public Health. 2012 Aug 20;12:677 [22905910.001]
  • [Cites] AIDS Care. 2006 Nov;18(8):1018-24 [17012094.001]
  • [Cites] Soc Sci Med. 2009 Jan;68(1):12-20 [18952342.001]
  • [Cites] Sex Transm Dis. 2013 Mar;40(3):264-70 [23403607.001]
  • [Cites] J Empir Res Hum Res Ethics. 2012 Oct;7(4):34-43 [23086046.001]
  • [Cites] Patient Educ Couns. 2011 Dec;85(3):454-60 [21208772.001]
  • [Cites] J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S32-5 [23673883.001]
  • [Cites] AIDS Care. 2011 Jun;23 Suppl 1:66-74 [21660752.001]
  • [Cites] Public Health Rep. 2010 Jan-Feb;125 Suppl 1:29-37 [20408385.001]
  • [Cites] Technol Innov. 2012 Apr 1;13(4):null [24353757.001]
  • [Cites] Am J Mens Health. 2011 Mar;5(2):140-51 [20413391.001]
  • [Cites] J Community Health. 2011 Jun;36(3):486-94 [21107895.001]
  • [Cites] Health Educ Behav. 2011 Jun;38(3):311-20 [21393625.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):252-71 [20528132.001]
  • [Cites] Prog Community Health Partnersh. 2007 Summer;1(2):161-8 [20208235.001]
  • [Cites] Soc Sci Med. 2008 Feb;66(4):911-21 [18155336.001]
  • [Cites] J Urban Health. 2010 Jul;87(4):617-30 [20361357.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):203-17 [20528129.001]
  • [Cites] Womens Health Issues. 2012 May-Jun;22(3):e293-301 [22483581.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):218-37 [20528130.001]
  • [Cites] J Transcult Nurs. 2009 Jan;20(1):28-36 [18955506.001]
  • [Cites] J Empir Res Hum Res Ethics. 2013 Feb;8(1):68-78 [23485672.001]
  • [Cites] Int Q Community Health Educ. 2010;31(2):133-54 [21840812.001]
  • [Cites] Harm Reduct J. 2007 Dec 08;4:20 [18067670.001]
  • [Cites] Soc Work. 2010 Jan;55(1):19-26 [20069937.001]
  • [Cites] J Health Care Poor Underserved. 2010 Aug;21(3 Suppl):148-68 [20675952.001]
  • [Cites] AIDS Educ Prev. 2011 Jun;23(3):236-48 [21696242.001]
  • [Cites] Prog Community Health Partnersh. 2012 Winter;6(4):451-6 [23221290.001]
  • [Cites] AIDS Educ Prev. 2012 Feb;24(1):41-53 [22339144.001]
  • [Cites] J Relig Health. 2014 Aug;53(4):1223-35 [24639068.001]
  • (PMID = 28066841.001).
  • [Journal-full-title] Jacobs journal of community medicine
  • [ISO-abbreviation] Jacobs J Community Med
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R29 HL044904; United States / NHLBI NIH HHS / HL / R29 HL044904-05
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acquired Immune Deficiency Syndrome / African Americans / American Indians / Asians and Pacific Islanders / Community-Based Participatory Research / HIV / Hispanics
  •  go-up   go-down


3. Pestana JM: Clinical outcomes of 11,436 kidney transplants performed in a single center - Hospital do Rim. J Bras Nefrol; 2017 Jul-Sep;39(3):287-295

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical outcomes of 11,436 kidney transplants performed in a single center - Hospital do Rim.
  • Therefore, efficient systems capable of performing high number of procedures are attractive and sustainable.
  • OBJECTIVE: The aim of this study was to evaluate clinical outcomes of 11,436 kidney transplants regularly performed in a single transplant dedicated center over the last 18 years.
  • All consecutive patients who underwent transplantation between 08/18/1998 and 12/31/2015 were included in the analysis.
  • RESULTS: The annual number of transplants increased from 394 in 1999 to 886 in 2015, with a progressive reduction in the proportion of living donor kidney transplants (70% vs. 23%) and yielding over 8869 patients in regular follow up.
  • Of 11,707 kidney transplants performed, 5348 (45.7%) were from living, 3614 (30.9%) standard and 1618 (13.8%) expanded criteria deceased donors, 856 (7.3%) pediatric and 271 (2.3%) simultaneous kidney-pancreas transplants.
  • Comparing 1998-2002 and 2011-2014, five-years graft survival increased for kidney transplants performed with living donors (83.3% vs. 93.1%, p < 0.001), standard deceased donors (60.7% vs. 79.7%, p < 0.001), expanded criteria donors (46.5% vs. 71.5%, p < 0.001) and for the pediatric population (79.8% vs. 80.9%, p = 0.684).
  • CONCLUSION: The implementation of a dynamic and efficacious health care system was associated with a progressive increase in the number of kidney transplants, in the cumulative number of patients in follow up and a shift from living related to deceased donor kidney transplants, with associated progressive increase in patient and graft survivals.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28902233.001).
  • [ISSN] 2175-8239
  • [Journal-full-title] Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
  • [ISO-abbreviation] J Bras Nefrol
  • [Language] eng; por
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


4. Johansen IH, Baste V, Rosta J, Aasland OG, Morken T: Changes in prevalence of workplace violence against doctors in all medical specialties in Norway between 1993 and 2014: a repeated cross-sectional survey. BMJ Open; 2017 Aug 11;7(8):e017757

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in prevalence of workplace violence against doctors in all medical specialties in Norway between 1993 and 2014: a repeated cross-sectional survey.
  • PARTICIPANTS: Representative samples of Norwegian doctors in 1993 (n=2628) and 2014 (n=1158).
  • MAIN OUTCOME MEASURES: Relative risk (RR) of self-reported prevalence of work-time experiences of threats and real acts of violence, and of being physically or psychologically unfit during the last 12 months due to fear of violence, in 2014 compared with 1993, adjusted by age, gender and medical specialty.
  • RESULTS: There were no differences in self-reported threats (adjusted RR=1.01, 95% CI 0.95 to 1.08) or real acts (adjusted RR=0.90, 95% CI 0.80 to 1.03) of violence when comparing 2014 with 1993.
  • The proportion of doctors who had felt unfit due to fear of violence decreased from 1993 to 2014 (adjusted RR=0.53, 95% CI 0.39 to 0.73).
  • Although still above average, the proportion of doctors in psychiatry who reported real acts of violence decreased substantially from 1993 to 2014 (adjusted RR=0.75, 95% CI 0.60 to 0.95).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
  • (PMID = 28801441.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aggression / Physical Abuse / Physician / Psychiatry / Workplace Violence
  •  go-up   go-down


5. Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B: Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014). Medicine (Baltimore); 2017 Feb;96(6):e5941
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014).
  • This population-based study aimed to evaluating various factors affecting the survival rate of CRC patients in Kurdistan province.In a retrospective cohort study, patients diagnosed as CRC were collected through a population-based study from March 1, 2009 to 2014.
  • The proportional-hazard model Cox was also used in order to consider the effects of different factors on survival including age at diagnosis, place of residence, marital status, occupation, level of education, smoking, economic status, comorbidity, tumor stage, and tumor grade.A total number of 335 patients affected by CRC were assessed and the results showed that 1- and 5-year survival rate were 87% and 33%, respectively.
  • According to the results of Cox's multivariate analysis, the following factors were significantly related to CRC survival: age at diagnosis (≥65 years old) (HR 2.08, 95% CI: 1.17-3.71), single patients (HR 1.62, 95% CI: 1.10-2.40), job (worker) (HR 2.09, 95% CI: 1.22-3.58), educational level: diploma or below (HR 0.61, 95% CI: 0.39-0.92), wealthy economic status (HR 0.51, 95% CI: 0.31-0.82), tumor grade in poorly differentiated (HR 2.25, 95% CI: 1.37-3.69), and undifferentiated/anaplastic grade (HR 2.90, 95% CI: 1.67-4.98).We found that factors such as low education, inappropriate socioeconomic status, and high tumor grade at the time of disease diagnosis were effective in the poor survival of CRC patients in Kurdistan province; this, which need more attention.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Cancer. 2010 Nov;46(16):2965-72 [20580545.001]
  • [Cites] Medicine (Baltimore). 2015 Jan;94(2):e431 [25590852.001]
  • [Cites] Int J Epidemiol. 2010 Jun;39(3):710-7 [20378687.001]
  • [Cites] Soc Sci Med. 2009 Jan;68(2):290-7 [19022550.001]
  • [Cites] BMC Public Health. 2015 Oct 01;15:997 [26423906.001]
  • [Cites] Med J Aust. 2011 Sep 19;195(6):350-4 [21929501.001]
  • [Cites] Eur J Cancer. 2008 Sep;44(14):1978-88 [18667301.001]
  • [Cites] Epidemiol Health. 2013 Jun 20;35:e2013004 [23807907.001]
  • [Cites] Eur J Surg Oncol. 2005 Oct;31(8):845-53 [15979269.001]
  • [Cites] BMC Cancer. 2009 Jul 13;9:227 [19594933.001]
  • [Cites] J Korean Soc Coloproctol. 2010 Dec;26(6):376 [21221236.001]
  • [Cites] BMC Cancer. 2009 Apr 20;9:116 [19379520.001]
  • [Cites] CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17 [24639052.001]
  • [Cites] Cancer. 2007 Aug 1;110(3):660-9 [17582625.001]
  • [Cites] Eur J Cancer. 2006 Nov;42(17):3041-8 [17029939.001]
  • [Cites] J Epidemiol Community Health. 2003 Apr;57(4):301-9 [12646548.001]
  • [Cites] J Clin Oncol. 2015 Mar 10;33(8):885-93 [25646196.001]
  • [Cites] Saudi J Gastroenterol. 2009 Jan;15(1):18-23 [19568550.001]
  • [Cites] Eur J Cancer. 2005 Oct;41(15):2297-303 [16140008.001]
  • [Cites] Cancer Epidemiol. 2016 Apr;41:63-70 [26828896.001]
  • [Cites] Patient Prefer Adherence. 2013 Aug 23;7:827-34 [24003305.001]
  • [Cites] Ann Oncol. 2008 Jan;19(1):156-62 [17785761.001]
  • [Cites] Eur J Cancer. 2008 Sep;44(14):1938-49 [18684615.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12(5):1225-31 [21875272.001]
  • [Cites] Med J Islam Repub Iran. 2014 Jul 27;28:83 [25664284.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(9):5111-6 [24175785.001]
  • [Cites] Dig Liver Dis. 2015 Jul;47(7):597-601 [25911573.001]
  • [Cites] Chin Med J (Engl). 2011 Jul;124(14):2132-5 [21933615.001]
  • [Cites] Cancer Lett. 2006 Aug 18;240(1):143-7 [16288832.001]
  • [Cites] Lancet. 2015 Mar 28;385(9974):1206-18 [25479696.001]
  • [Cites] Am J Surg. 2011 Nov;202(5):574-82 [21872205.001]
  • [Cites] Dis Colon Rectum. 2000 Sep;43(9):1222-6 [11005487.001]
  • [Cites] Arch Iran Med. 2014 Mar;17(3):193-7 [24621363.001]
  • [Cites] Eur J Cancer. 2012 Jan;48(1):46-53 [21676610.001]
  • [Cites] Colorectal Dis. 2009 Feb;11(2):157-61 [18462239.001]
  • [Cites] J Natl Cancer Inst. 2007 Sep 19;99(18):1384-94 [17848670.001]
  • [Cites] Gut. 2011 Aug;60(8):1087-93 [21303917.001]
  • [Cites] Am J Public Health. 2011 Jan;101(1):112-9 [20299655.001]
  • [Cites] Br J Cancer. 1995 Mar;71(3):637-41 [7880750.001]
  • [Cites] Dis Colon Rectum. 2004 Dec;47(12):2064-9 [15657655.001]
  • [Cites] Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):583-6 [19827873.001]
  • [Cites] Ann Thorac Surg. 2005 Jan;79(1):278-82; discussion 283 [15620957.001]
  • [Cites] Asian J Surg. 2010 Jul;33(3):127-33 [21163410.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3134-40 [18990755.001]
  • [Cites] BMC Cancer. 2007 Oct 16;7:193 [17939875.001]
  • [Cites] Clin Transl Oncol. 2012 Dec;14(12):896-904 [22855164.001]
  • [Cites] J Surg Oncol. 2002 Mar;79(3):157-65 [11870666.001]
  • [Cites] Int J Clin Oncol. 2010 Dec;15(6):559-64 [20602136.001]
  • [Cites] Medicine (Baltimore). 2015 Sep;94(35):e1402 [26334895.001]
  • [Cites] Eur J Cancer. 2001 Jul;37(11):1402-8 [11435072.001]
  • [Cites] J Korean Soc Coloproctol. 2010 Dec;26(6):424-8 [21221244.001]
  • [Cites] Eur J Cancer. 2007 Oct;43(15):2279-84 [17904353.001]
  • [Cites] J Epidemiol Community Health. 2010 Feb;64(2):117-23 [20056966.001]
  • [Cites] J Am Geriatr Soc. 2006 Dec;54(12):1898-904 [17198496.001]
  • [Cites] Cancer Epidemiol. 2011 Oct;35(5):417-22 [21466984.001]
  • [Cites] Epidemiol Rev. 1998;20(1):81-90 [9762511.001]
  • [Cites] Health Place. 2012 Mar;18(2):321-9 [22118939.001]
  • [Cites] Cancer Causes Control. 2005 Jun;16(5):501-13 [15986105.001]
  • (PMID = 28178134.001).
  • [ISSN] 1536-5964
  • [Journal-full-title] Medicine
  • [ISO-abbreviation] Medicine (Baltimore)
  • [Language] eng
  • [Publication-type] Journal Article; Observational Study
  • [Publication-country] United States
  •  go-up   go-down


6. Undurraga EA, Meltzer MI, Tran CH, Atkins CY, Etheart MD, Millien MF, Adrien P, Wallace RM: Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015. Am J Trop Med Hyg; 2017 Jun;96(6):1307-1317
MedlinePlus Health Information. consumer health - Rabies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015.
  • Our evaluation encompassed all individuals exposed to rabies in the study area (<i>N</i> = 2,289) in 2014-2015.
  • Costs (2014 U.S. dollars) included diagnostic laboratory development, training of surveillance officers, operational costs, and postexposure prophylaxis (PEP).
  • HARSP had higher overall costs (range: $39,568-$80,290) than the no-bite-case-management (NBCM) scenario ($15,988-$26,976), partly from an increased number of bite victims receiving PEP.
  • But HARSP had better health outcomes than NBCM, with estimated 11 additional annual averted deaths in 2014 and nine in 2015, and 654 additional YLG in 2014 and 535 in 2015.
  • Overall, HARSP was more cost-effective (US$ per death averted) than NBCM (2014, HARSP: $2,891-$4,735, NBCM: $5,980-$8,453; 2015, HARSP: $3,534-$7,171, NBCM: $7,298-$12,284).

  • Genetic Alliance. consumer health - Rabies.
  • MedlinePlus Health Information. consumer health - Animal Bites.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bull World Health Organ. 1993;71(5):615-24 [8261565.001]
  • [Cites] Emerg Infect Dis. 2013 Apr;19(4):678-9 [23750499.001]
  • [Cites] Lancet Infect Dis. 2002 Jun;2(6):327-43 [12144896.001]
  • [Cites] Emerg Infect Dis. 2007 Jan;13(1):136-9 [17370529.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Nov 24;9(11):e0004245 [26600437.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003806 [26110845.001]
  • [Cites] PLoS Negl Trop Dis. 2010 Feb 23;4(2):e626 [20186330.001]
  • [Cites] Emerg Infect Dis. 2004 Jan;10(1):140-2 [15078611.001]
  • [Cites] PLoS Negl Trop Dis. 2008;2(11):e339 [19030223.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120143 [23798691.001]
  • [Cites] Transbound Emerg Dis. 2017 Jun;64(3):951-958 [26916104.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 20;64(6):137-40 [25695317.001]
  • [Cites] Epidemiol Infect. 2017 Jun;145(8):1624-1634 [28290915.001]
  • [Cites] Vaccine. 2009 Nov 27;27(51):7167-72 [19925948.001]
  • [Cites] Virus Res. 2005 Jul;111(1):5-12 [15896398.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709 [25881058.001]
  • [Cites] PLoS Biol. 2009 Mar 10;7(3):e53 [19278295.001]
  • [Cites] Bull World Health Organ. 2005 May;83(5):360-8 [15976877.001]
  • [Cites] Prev Vet Med. 2010 Oct 1;97(1):51-7 [20696487.001]
  • [Cites] Lancet. 2014 Oct 11;384(9951):1389-99 [24828901.001]
  • [Cites] Front Vet Sci. 2017 Feb 10;4:9 [28239608.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2063-6 [23245602.001]
  • [Cites] Vaccine. 2002 Sep 10;20(27-28):3332-41 [12213403.001]
  • [Cites] Bull World Health Organ. 2002;80(4):304-10 [12075367.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Mar 08;5(3):e982 [21408121.001]
  • (PMID = 28719253.001).
  • [ISSN] 1476-1645
  • [Journal-full-title] The American journal of tropical medicine and hygiene
  • [ISO-abbreviation] Am. J. Trop. Med. Hyg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Rabies Vaccines
  •  go-up   go-down


7. Saurabh S, Prateek S: Role of contact tracing in containing the 2014 Ebola outbreak: a review. Afr Health Sci; 2017 Mar;17(1):225-236

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of contact tracing in containing the 2014 Ebola outbreak: a review.
  • BACKGROUND: The 2014 outbreak of Ebola virus disease which emerged in the month of March in the year 2014 in Guinea has been declared as a public health emergency of international concern.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):386-8 [25879897.001]
  • [Cites] Euro Surveill. 2015 Jan 08;20(1):null [25613652.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2014 Nov 7;63(44):1010-2 [25375073.001]
  • [Cites] Ann Intern Med. 2015 Aug 4;163(3):164-73 [26005809.001]
  • [Cites] JAMA. 2014 Nov 12;312(18):1859-60 [25285459.001]
  • [Cites] Mod Healthc. 2014 Aug 18;44(33):24 [25318255.001]
  • [Cites] Pan Afr Med J. 2014 Sep 22;19:48 [25667710.001]
  • [Cites] J Infect Dev Ctries. 2014 Nov 13;8(11):1378-80 [25390049.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):175-8 [25719678.001]
  • [Cites] Infect Dis Poverty. 2015 Jan 09;4(1):7 [25671127.001]
  • [Cites] Germs. 2014 Dec 01;4(4):97-9 [25505743.001]
  • [Cites] Disaster Med Public Health Prep. 2015 Oct;9(5):595-7 [25913044.001]
  • [Cites] Ann Afr Med. 2015 Oct-Dec;14(4):200-1 [26470746.001]
  • [Cites] Global Health. 2012 Jun 13;8:15 [22695277.001]
  • [Cites] Science. 2014 Nov 21;346(6212):991-5 [25414312.001]
  • [Cites] Med Mal Infect. 2014 Dec;44(11-12):491-4 [25391486.001]
  • [Cites] J Theor Biol. 2015 Nov 7;384:33-49 [26297316.001]
  • [Cites] Glob J Health Sci. 2015 May 17;8(1):72-8 [26234990.001]
  • [Cites] Lancet. 2014 Apr 5;383(9924):1196 [24712029.001]
  • [Cites] Disaster Med Public Health Prep. 2015 Oct;9(5):554-7 [26330281.001]
  • [Cites] BMJ. 2014 Sep 04;349:g5485 [25193934.001]
  • [Cites] Lancet Infect Dis. 2014 Dec;14(12):1163 [25455967.001]
  • [Cites] JAMA. 2015 Feb 10;313(6):567-8 [25532102.001]
  • [Cites] East Mediterr Health J. 2015 Feb 02;20(12):759-60 [25664512.001]
  • [Cites] Am J Infect Control. 2015 Jul 1;43(7):669-75 [25920703.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 May 15;64(18):500-4 [25974635.001]
  • [Cites] Euro Surveill. 2015 Jan 08;20(1):null [25613651.001]
  • [Cites] BMJ. 2014 Oct 17;349:g6305 [25326005.001]
  • [Cites] Turk J Med Sci. 2015;45(1):1-5 [25790522.001]
  • [Cites] Afr Health Sci. 2014 Dec;14(4):1085 [25834522.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):183-5 [25719680.001]
  • [Cites] N Engl J Med. 2014 Sep 25;371(13):1183-5 [25140856.001]
  • [Cites] J Res Med Sci. 2015 Mar;20(3):318-9 [26109982.001]
  • [Cites] J Glob Infect Dis. 2015 Apr-Jun;7(2):53-5 [26069422.001]
  • [Cites] Public Health Rep. 2015 Mar-Apr;130(2):118-20 [25729097.001]
  • [Cites] Int J Health Policy Manag. 2014 Nov 01;3(7):417-8 [25489601.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2015 Aug;109(8):481-2 [26160255.001]
  • [Cites] MMW Fortschr Med. 2015 Aug 20;157(14):50-2 [26289887.001]
  • [Cites] Int J Infect Dis. 2004 Jan;8(1):27-37 [14690778.001]
  • [Cites] Euro Surveill. 2015 Mar 26;20(12):null [25846487.001]
  • [Cites] Trop Med Int Health. 2015 Apr;20(4):448-54 [25565430.001]
  • [Cites] PLoS Negl Trop Dis. 2015 May 29;9(5):e0003794 [26024528.001]
  • [Cites] BMC Public Health. 2012 Nov 21;12:1014 [23170851.001]
  • [Cites] BMJ. 2014 Aug 08;349:g5089 [25106874.001]
  • [Cites] J Nurs Res. 2015 Sep;23(3):217-24 [26270268.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):179-82 [25719679.001]
  • [Cites] Int J Prev Med. 2015 Oct 01;6:96 [26605017.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 13;64(5):121-3 [25674993.001]
  • [Cites] Zhonghua Yu Fang Yi Xue Za Zhi. 2015 May;49(5):450-1 [26081711.001]
  • [Cites] J Res Med Sci. 2015 Jan;20(1):107-8 [25767533.001]
  • (PMID = 29026397.001).
  • [ISSN] 1729-0503
  • [Journal-full-title] African health sciences
  • [ISO-abbreviation] Afr Health Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Uganda
  • [Keywords] NOTNLM ; Ebola virus disease / West-Africa / World Health Organization / contact tracing
  •  go-up   go-down


8. Rajendra A, Spivakovsky S: Antibiotics in aggressive periodontitis, is there a clinical benefit? Evid Based Dent; 2016 12;17(4):100

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data sourcesMedline, Embase and CENTRAL databases were searched up to December 2014.
  • Only two of the 11 included trials were considered at a low risk of bias.
  • The six studies evaluated in the pairwise meta-analyses were excluded in the pooled estimates because four studies included patients with advanced disease only and one study did not present average data for pocket depth (PD) and clinical attachment level (CAL) and another one for using a different mechanical treatment.ResultsFourteen studies reporting 11 randomised clinical trials with a total of 388 patients were included in the review.
  • Nine of 11 studies reported a statistically significant greater gain in full mouth mean clinical attachment (CA) and reduction in probing depth (PD) when a systemic antibiotic was used.
  • From those studies the calculated mean difference for CA gained was 1.08 mm (p < 0.0001) and for PD reduction was 1.05 mm (p< 0.00001) for SRP + Metronidazole (Mtz).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Clin Periodontol. 2015 Jul;42(7):647-57 [26087839.001]
  • (PMID = 27980332.001).
  • [ISSN] 1476-5446
  • [Journal-full-title] Evidence-based dentistry
  • [ISO-abbreviation] Evid Based Dent
  • [Language] eng
  • [Publication-type] Journal Article; Comment
  • [Publication-country] England
  •  go-up   go-down


9. Zhu J, Yuan R, Hu D, Zhu ZB, Yang X, Wang N, Wang B: [Consecutive cross-sectional survey of prevalence of HIV infection/STD and related factors in Vietnamese female sex workers at a China-Vietnam border area, 2014-2015]. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May 10;38(5):638-642
MedlinePlus Health Information. consumer health - Sexually Transmitted Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Consecutive cross-sectional survey of prevalence of HIV infection/STD and related factors in Vietnamese female sex workers at a China-Vietnam border area, 2014-2015].
  • <b>Methods:</b> Consecutive cross-sectional surveys were conducted in June 2014, December 2014, May 2015 and November 2015 in Hekou, a county bordering Vietnam in Yunnan province.
  • <b>Results:</b> The consecutive cross sectional surveys indicated that the prevalence of HIV infection in Vietnamese FSWs were 3.20<i>%</i>(7/219), 2.04<i>%</i>(5/245), 1.89<i>%</i>(5/265) and 1.82<i>%</i>(6/329) respectively; the HSV-2 positive rates were 57.08<i>%</i>(125/219), 58.37<i>%</i>(143/245), 38.11<i>%</i>(101/265) and 51.06<i>%</i> (168/329) respectively.
  • By logistic regression analysis, the related factors for HIV infection in Vietnamese FSWs were being amphetamine type stimulants (ATS) positive (<i>OR</i>=10.18, 95<i>%CI</i>: 4.33-23.92) and being HSV-2 positive (<i>OR</i>=2.89, 95<i>%CI</i>: 1.09-7.88); Age (<i>OR</i>=1.88, 95<i>%CI</i>: 1.32-2.61), no-paid sexual partner (<i>OR</i>=1.59, 95<i>%CI</i>: 1.26-2.01) and being ATS positive (<i>OR</i>=2.48, 95<i>%CI</i>: 1.10-5.57) were related factors for HSV-2 infection.
  • <b>目的:</b> 了解越南籍暗娼HIV/性传播疾病(STD)感染及其相关因素。 <b>方法:</b> 分别于2014年6月、12月和2015年5月、11月,在云南省河口县开展连续横断面调查,采用方便抽样方式纳入年龄≥16周岁的越南籍暗娼共1 058人。问卷调查收集越南籍暗娼人口学特征、性行为及吸毒行为等信息;血液和尿液样本检测分析HIV/STD感染及毒品使用。应用趋势<i>χ</i>(2)检验分析越南籍暗娼HIV/STD感染和毒品使用及变化趋势,应用logistic回归分析HIV/STD感染的相关因素。 <b>结果:</b> 连续横断面调查中,越南籍暗娼的HIV感染率分别为3.20<i>%</i>(7/219)、2.04<i>%</i>(5/245)、1.89<i>%</i>(5/265)和1.82<i>%</i>(6/329);2型单纯疱疹病毒(HSV-2)感染率为57.08<i>%</i>(125/219)、58.37<i>%</i>(143/245)、38.11<i>%</i>(101/265)和51.06<i>%</i>(168/329);梅毒感染率为0.91<i>%</i>(2/219)、1.51<i>%</i>(4/245)、0.75<i>%</i>(2/265)、1.22<i>%</i>(4/329)。HSV-2感染率呈现下降趋势(<i>χ</i>(2)=4.823,<i>P</i>=0.028)。logistic回归分析结果显示,越南籍暗娼HIV感染的相关因素包括:甲基安非他明(ATS)阳性(<i>OR</i>=10.18,95<i>%CI</i>:4.33~23.92)和HSV-2阳性(<i>OR</i>=2.89,95<i>%CI</i>:1.09~7.88)。年龄(<i>OR</i>=1.88,95<i>%CI</i>:1.32~2.61)、非付费性伴(<i>OR</i>=1.59,95<i>%CI</i>:1.26~2.01)及ATS阳性(<i>OR</i>=2.48,95<i>%CI</i>:1.10~5.57)是越南籍暗娼HSV-2感染的相关因素。 <b>结论:</b> 越南籍暗娼HIV感染率较过去有所下降,HSV-2感染率有下降趋势但仍然较高。ATS使用与HIV/HSV-2感染有关联,应该对越南籍暗娼加强控制新型毒品和性传播疾病的综合性干预措施。.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28651402.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Female sex workers from Vietnam / HIV / Sexually transmitted diseases
  •  go-up   go-down


10. Muchena G, Shambira G, Masuka N, Juru T, Gombe N, Takundwa L, Bangure D, Tshimanga M: Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014. Int J Tuberc Lung Dis; 2017 Nov 01;21(11):1167-1172

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
  • RESULTS: Risk factors for MDR-TB were history of nursing an MDR-TB patient (adjusted OR [aOR] 4.46, 95%CI 2.02-9.88), history of hospitalisation for 3 days (aOR 2.91, 95%CI 1.62-5.23) and history of foreign travel and stay outside Zimbabwe (aOR 2.68, 95%CI 1.46-4.91).
  • Protective factors were previous successful treatment (aOR 0.05, 95%CI 0.02-0.11), history of supervision by a health worker/village health worker (aOR 0.34, 95%CI 0.19-0.60) and having been treated not more than once previously for TB (aOR 0.18, 95%CI 0.08-0.38).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29037298.001).
  • [ISSN] 1815-7920
  • [Journal-full-title] The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • [ISO-abbreviation] Int. J. Tuberc. Lung Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  •  go-up   go-down